Johnson & Johnson's Zytiga Helps Increase Survival Rate For Patient With Severe Prostate Cancer Medicine & Technology Jun 05, 2017 American Society of Clinical Oncology (ASCO) presented the research of the effectiveness of Zytiga to boost the survival rate for severe prostate cancers.
Pharaoh's Curse Unlocked? Scientists Claim To Have Cracked the Mystery of What Killed Over 20 People Who Opened the Tomb of King Tut in 1922
Humans Will Go Extinct on Earth in 250 Million Years; Mass Extinction Will Occur Sooner if Burning Fossil Fuels Continues [Study]
Synthetic Cells Created Using Programmable Peptide-DNA Technology Act Like Living Ones With Capabilities for Biomedical Advancements